See also this year's filing and all EDGAR filings for this company.
PDF Report 0001601485_2023_Elicio_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001601485, Elicio Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,430,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 273,000 |
| 3 | remainder_Assets | 1,087,000 |
| 4 | LiabilitiesCurrent | 6,369,000 |
| 5 | LiabilitiesNoncurrent | 2,481,000 |
| 6 | remainder_Liabilities | 168,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,637,000 |
| 9 | ResearchAndDevelopmentExpense | 18,100,000 |
| 10 | remainder_Expenses | 9,185,000 |
| 11 | remainder_Revenues | 2,301,000 |
| 12 | remainder_NetIncome | 814,000 |
| 13 | remainder_ComprehensiveNetIncome | 189,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 52,790,000 |
| 1 | Liabilities | 9,018,000 |
| 2 | Expenses | 41,922,000 |
| 3 | Revenues | 2,301,000 |
| 4 | StockholdersEquity | 43,772,000 |
| 5 | NetIncome | -38,807,000 |
| 6 | ComprehensiveNetIncome | -38,712,500 |
| 7 | BaseVar | 53,517,000 |
| 8 | EconomicCapitalRatio | 1.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
